Status Plus

Thursday, March 1, 2018

Thursday, March 1, 2018

Print This Page
Session type:
Clear filters


07:30 a.m. - 08:30 a.m.

Sponsored breakfast symposium (non-CME)

Location: Auditorium II

08:30 a.m. - 10:00 a.m.

Male sexual dysfunction

Location: Auditorium I
Moderators: Sidney Glina (Brazil) & Lawrence Hakim (USA)

08:30 a.m. - 09:00 a.m.

Total phallic reconstruction

David Ralph (United Kingdom)

09:00 a.m. - 09:30 a.m.

The new algorythm for the treatment of Peyronie's Disease

Eric Chung (Australia)

09:30 a.m. - 10:00 a.m.

Testosterone treatment, indications and safety

Mario Maggi (Italy)

08:30 a.m. - 10:00 a.m.

ESSM grant reports

Location: Auditorium II
Moderators: Javier Angulo Frutos (Spain) & Trinity Bivalacqua (USA)

The endogenous neurotrophin galanin as a strategy for erectile function rehabilitation after radical prostatectomy

Emmanuel Weyne (Belgium)

Development of a decision aid for genital surgery in transmen

Mujde Ozer (The Netherlands)

Discovery of novel drugs for Peyronie’s disease through phenotypic screening

Selim Cellek (United Kingdom)

08:30 a.m. - 10:00 a.m.

Podium session 1 - Female sexual function

Location: Room 5 B/C in Pavilion 5
Moderators: Kwangsung Park (Korea) & Mona Reda (Egypt)

The importance of male ejaculation for female sexual satisfaction and orgasm ability (#001)

Andrea Burri (United Kingdom)

Preliminary validation of the short symptom screener for women (SCS-W) (#002)

Andrea Burri (United Kingdom)

Effects of age on the subjective sexual response and emotional appraisal of sex pictures in women (#003)

J. Carvalho (Portugal)

Sexual dysfunctions in a sample of female Egyptians diagnosed with obsessive compulsive disorder (#004)

Mona Reda (Egypt)

The effects of learned sex-disgust associations on female sexual response (#005)

Charmaine Borg (The Netherlands)

Genital and subjective sexual response in women with the Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome with a non-surgically created neo-vagina (#006)

P. Weijenborg (The Netherlands)

Bremelanotide (BMT) for hypoactive sexual desire disorder (HSDD): efficacy analyses from the RECONNECT studies (#007)

Anita Clayton (USA)

Bremelanotide provides meaningful treatment benefits for premenopausal women with hypoactive sexual desire disorder (#008)

J. Lucas (USA)

Comparing symptom networks of women with reduced, increased, and stable sexual desire (#009)

A. Gunst (Finland)

Reversible neurogenic sexual dysfunction caused by lumbar and/or sacral pathology within the cauda equina (#010)

Irwin Goldstein (USA)

Pilot prospective vulvoscopic study examining changes to the vulva, vestibule, and vagina in women with genitourinary syndrome of menopause taking ospemifene (#011)

Sue Goldstein (USA)

Sexual function in women with obstetric anal sphincter injuries in the postpartum period. Analysis according to the mode of delivery (#012)

S.A.A. Anglès (Spain)

Alternative rights of passage: a new model to end FGM (#013)

J. Osur (Kenya)

Do experts for vulva diseases integrate sexual health problems in daily diasease-managment _ self-assessment results at the 10th anniversary of the interdisciplinarey Vulva-Workshop, VIVE-EV_Graz, September 2017 (#014)

B. Eberz (Austria)

A randomized, wait list-controlled trial suggests that two psychobehavioral interventions are effective for women’s hypoactive sexual desire (#015)

Patrick Jern (Finland)

09:00 a.m. - 10:00 a.m.

WAS symposium - From sexual science to sexual health and sexual rights

Location: Auditorium III
Moderator: Pedro Nobre (Portugal)

09:00 a.m. - 09:20 a.m.

The World Association for Sexual Health: Promoting evidence-based sexual health and sexual rights

Pedro Nobre (Portugal)

09:20 a.m. - 09:40 a.m.

The full gamut of sexual health care

Woet Gianotten (The Netherlands)

09:40 a.m. - 10:00 a.m.

Sexual pleasure, a sexual right often neglected in research

Patricia Pascoal (Portugal)

10:00 a.m. - 10:30 a.m.

Coffee break and poster tours

Location: Pavilion 4 and 5

10:00 a.m. - 10:30 a.m.

Moderated poster tour 1 - Sexual identity (orientation), gender identity and sexual preference

Location: Pavilion 5
Moderators: Alan Shindel (USA) & Kevan Wylie (United Kingdom)

Neural mechanisms underlying pedophilia and sexual offending against children - first results of a multicenter study (#201)

J. Engel (Germany)

Development, validation, and results from a novel inventory to assess and compare gender dysphoria before and after genital gender affirming surgery (#202)

M. Garcia (USA)

Barriers to post-transgender surgery care in the federal prison system (#203)

M. Garcia (USA)

The “functional magnetic resonance imaging” (fMRI) as a meaningful tool for the differentiation of sexual preferences (#204)

J.L. Kunath (Germany)

A longitudinal study of motivations before and psychosexual outcomes after genital gender confirming surgery in transmen (#205)

Tim van de Grift (The Netherlands)

Influence of partner sexuality on the sexual activity of aged men and women (#206)

N. Ati (Tunisia)

10:00 a.m. - 10:30 a.m.

Moderated poster tour 2 - Priapism & Peyronie's disease

Location: Pavilion 5
Moderators: Emre Akkus (Turkey) & Osama Shaeer (Egypt)

The Comparison of an acellular matrix graft (Xenoguardtm) with an autologous venous graft in the surgical treatment of Peyronie’s Disease (#207)

O. Kayigil (Turkey)

Preliminary outcomes of Collagenase Clostridium Histolyticum (CCH) using a modified technique “Percutaneous Needling Tunneling (PNT)” in the treatment of Peyronie's Disease (PD): prospective randomized study (#208)

E. Fernández-Pascual (Spain)

Peyronie’s Disease : predictive factors of good response to collagenase clostridium hystoliticum injections therapy (#209)

Marco Capece (Italy)

Novel injection method using a Collagenase Clostridium histolyticum in Peyronie’s Disease (#210)

Z. Zotter (Hungary)

Ultrasound predictive factors for efficacy and safety of the use of Collagenase Clostridium Histolyticum (CCH) in the treatment of Peyronie's disease (PD): Impact of patient´s selection (#211)

E. Fernández-Pascual (Spain)

Emergency room visits are reduced in patients using type 5 phosphodiesterase inhibitors for recurrent priapism (#212)

E. Rajih (Saudi Arabia)

10:00 a.m. - 10:30 a.m.

Moderated poster tour 3 - Basic research 1

Location: Pavilion 5
Moderators: Ganesh Adaikan (Singapore), Fabio Castiglione (Italy) & Kelvin Davies (USA)

Nrf2 activation improves both hyperpolarization- and NO-mediated responses in penile vasculature from patients with erectile dysfunction (#213)

J. Angulo (Spain)

Efficient promotion of autophagy and angiogenesis by combination therapy with low-energy shockwaves and mesenchymal stem cells in the treatment of erectile dysfunction (#214)

W.J. Bae (Korea)

Mechanisms underlying the sexual inhibitory effect of tramadol; a study in serotonin transporter knockout rats (#215)

D.C. Esquivel Franco (The Netherlands)

Functional effects of the monoamine reuptake inhibitor, IPED2015 in both cerebral and erectile tissue in vitro (#216)

S. Comerma-Steffensen (Denmark)

Neuropraxia following nerve sparing radical prostatectomy is associated with increased expression of markers of inflammation and Fidgetin-2 like protein (#217)

G. Villegas (USA)

Inhibition of microRNA-92a improved erectile dysfunction in streptozotocin-induced diabetic rats via suppressing oxidative stress and endothelial dysfunction (#218)

Z. Tang (China)

10:00 a.m. - 10:30 a.m.

Moderated poster tour 4 - ED: epidemiology

Location: Pavilion 5
Moderators: Sae Woong Kim (Korea) & John Mulhall (USA)

Probability of erectile function recovery in young men treated with radical prostatectomy – findings of a contemporary series (#219)

W. Cazzaniga (Italy)

Temporal trend in patients’ age at first assessment for erectile dysfunction (#220)

Eugenio Ventimiglia (Italy)

Erectile dysfunction and associated risk factors in infertile Chinese men (#221)

Y. Bin (China)

Global prevalence, patient profiles, and health outcomes of erectile dysfunction (ED) among 40-70 year-old men (#222)

Irwin Goldstein (USA)

Impact of time from diagnosis to treatment on erectile function outcomes after radical prostatectomy (#223)

W. Cazzaniga (Italy)

Sexual dysfunction among Greek patients with multiple sclerosis (#224)

M. Tzitzika (Greece)

10:00 a.m. - 10:30 a.m.

Moderated poster tour 5 - Ejaculation and its associated problems

Location: Pavilion 5
Moderators: Shinichi Hisasue (Japan) & Kevin McVary (USA)

Vacuum therapy in ED: outcomes from a specialist vacuum clinic (#225)

S.J. Megarity (United Kingdom)

Sexuality in adult male patients with anorectal malformations (#226)

S. Eleuteri (Italy)

The effect of buspirone on refractory neurogenic retrograde ejaculation to pseudoephedrine (#227)

S.T. Ahn (Korea)

Lower urinary tract symptoms among patients presenting for premature ejaculation (#228)

Andrea Salonia (Italy)

How does premature ejaculation affect erectile function? (#229)

J. Peng (China)

Metabolic syndrome is an independent risk factor for acquired premature ejaculation (#230)

S.U. Jeh (Korea)

10:30 a.m. - 11:00 a.m.

Late breaking abstracts

Location: Auditorium II
Moderators: Kwangsung Park (Korea) & Guy T'Sjoen (Belgium)

Tadalafil 5 mg effectiveness in the treatment of lower urinary tract symptoms suggestive to benign prostatic hyperplasia with erectile dysfunction (#165)

N. Ati (Tunisia)

Enjoy yourself, it's later than you think! (#166)

S.J. Megarity (United Kingdom)

Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials (#167)

K. van Rooij (The Netherlands)

Effect of a Trigonella foenum graecum-based food supplement on sexual function in women with low sexual desire. Pilot study (#168)

M. Lilue (Spain)

Do international experts in fertility preservation adress sexual problems in fertility-treatment? Igls-Vienna-SexMed-Survey-Program: Reproductive Medicine Experts' Self-Assessment-Results at the 5th biennal World Congress for Fertility Preservation, Vienn

L. Ucsnik (Austria)

10:30 a.m. - 11:30 a.m.

Workshop: Step care approach for managing premature ejaculation

Location: Auditorium III
Faculty: Evie Kirana (Greece) & Ege Can Serefoglu (Turkey)

10:30 a.m. - 12:30 p.m.

Podium session 2 - Basic research

Location: Room 5 B/C in Pavilion 5
Moderators: Johanna Hannan (USA) & Hotaka Matsui (Japan)

Antifibrotic effect of mycophenolate mofetil experimentally induced Peyronie's Disease with TGF-B (#016)

F.N. Facio Junior (Brazil)

Anti-fibrotic properties of RhoA kinase-inhibition in a cell culture model of Peyronie’s Disease (#017)

U. Milenkovic (Belgium)

Antagonizing penile smooth muscle contraction by inhibition of orai calcium channels. A potential therapeutic target in erectile dysfunction (#018)

J. Angulo (Spain)

Galanin mediates endogenous nitrinergic nerve outgrowth in vitro and partially restores erectile function after cavernous nerve injury in vivo (#019)

Emmanuel Weyne (Belgium)

Prostatic radiation therapy increases neuronal apoptosis, decreases nitrergic neurons and markedly impairs neuritogenesis in the major pelvic ganglion (#020)

Johanna Hannan (USA)

Potential role of 5-HT serotonin system in the rat spinal cord of premature ejaculation with category III prostatitis (#021)

Y. Zhang (China)

Vardenafil and Tamoxifen synergise in a rat model of Peyronie’s disease (#022)

M.M. Ilg (United Kingdom)

Persistent erectile dysfunction after discontinuation of 5-alpha reductase inhibitor therapy in rats depending on the duration of treatment (#023)

S.W. Lee (Korea)

JAK2 knockout improves erectile function in diabetic mice through attenuation of fibrosis and apoptosis (#024)

H. Li (China)

Dickkopf2 reprograms damaged erectile tissue toward neurovascular repair through an angiopoietin-1-Tie2 pathway in mice with diabetes mellitus or cavernous nerve injury (#025)

J.K. Suh (Korea)

Testosterone deficiency causes endothelial dysfunction via elevation of asymmetric dimethylarginine (ADMA) and oxidative stress in castrated rats (#026)

Tomoya Kataoka (Japan)

Mirabegron elicits recovery of erectile function in a rat model of streptozotocin-induced diabetes (#027)

E. Kaya Sezginer (Turkey)

TNF-alpha inhibition can prevent smooth-muslce dysfunction following bilateral cavernous nerve injury by upregulating GFAP expression through activation of ERK1/ERK2 signaling (#028)

Hotaka Matsui (Japan)

A novel dopamine reuptake inhibitor, IPED2015 induces spontaneous erections through activation of dopamine receptors in rats (#029)

S. Comerma-Steffensen (Denmark)

Light-controlled relaxation of rat penile corpus cavernosum by a novel NO donor, NO-Rosa (#030)

Y. Hotta (Japan)

Low intensity-shockwave therapy (Li-ESWT) delivered by Aries® improves erectile function and decreases cavernosal fibrosis of spontaneously hypertensive rats (SHR) (#031)

Francois Giuliano (France)

An evolving hypothesis on the mechanism and efficacy of intracavernosal injection of botulinum toxin to improve erectile function: an animal study in aging rats (#032)

N. Punjani (Canada)

Effect of testosterone on vaginal function in an experimental rat model (#033)

E. Maseroli (Italy)

Topical application of Sildenafil-nanoparticles (proximal and distal) improve erectile function in an aging-rat model of erectile dysfunction (#034)

M.T. Tar (USA)

The mechanisms of stress-induced erectile dysfunction; a focus on regulators of contraction and relaxation in the corpus cavernosum by using a rat model of water immersion-restraint stress (#035)

T. Mori (Japan)

10:30 a.m. - 12:30 p.m.

Sponsored live surgery (non-CME)

Location: Auditorium I

11:00 a.m. - 12:30 p.m.

Round table - Hypersexuality, a 2018 update

Location: Auditorium II
Moderators: Pedro Nobre (Portugal), Miguel Rivero (Argentina) & Chiara Simonelli (Italy)

11:00 a.m. - 11:15 a.m.

Sexual addiction and its relation to forensic psychiatry

Peer Briken (Germany)

11:15 a.m. - 11:30 a.m.

Is high sexual desire a risk for women's relationship and sexual well-being?

Chiara Simonelli (Italy)

11:30 a.m. - 11:45 a.m.

Emotional dysregulation and hypersexuality – Clinical implications

Mohammad Shamsul Ahsan (Bangladesh)

11:45 a.m. - 12:00 p.m.

Neurobiological basis of hypersexuality

James Pfaus (Canada)

12:00 p.m. - 12:30 p.m.


11:30 a.m. - 12:30 p.m.

Workshop: Sex design: What the practitioner needs to know about female genital aesthetic interventions and vaginal rejuvination

Location: Auditorium III
Faculty: Michael Krychman (USA) & Lior Lowenstein (Israel)


12:30 p.m. - 02:00 p.m.

Lunch break

Location: Pavilion 4

02:00 p.m. - 03:00 p.m.

Sexually transmitted diseases, risk groups and prevention

Location: Auditorium I
Moderators: Abdulaziz Baazeem (Saudi Arabia), Odunayo Kalejaiye (United Kingdom) & Sérgio Tavares dos Santos (Portugal)

02:00 p.m. - 02:15 p.m.

Epidemiology of STI in 2018: a global perspective

Melanie Taylor (United Kingdom)

02:15 p.m. - 02:30 p.m.

Are risk groups evolving? Who should be screened in 2018?

Alan Shindel (USA)

02:30 p.m. - 02:45 p.m.

HIV pre- and post exposure prophylaxis: who, what, when?

Shalini Andrews (United Kingdom)

02:45 p.m. - 03:00 p.m.

HPV: a preventable cause of cancer

Ira Sharlip (USA)

02:00 p.m. - 03:00 p.m.

Workshop: Penile cancer: Treatment options and sexual consequences

Location: Auditorium III
Faculty: Asif Muneer (United Kingdom) & Arie Parnham (United Kingdom)

02:00 p.m. - 04:00 p.m.

State of the art in male orgasm disorders

Location: Auditorium II
Moderators: Francois Giuliano (France), Emmanuele Jannini (Italy) & Augusto José Pepe Cardoso (Portugal)

02:00 p.m. - 02:30 p.m.

Novelty in PE treatment (non-CME)

Vincenzo Mirone (Italy)

02:30 p.m. - 02:45 p.m.

A deeper insight in lifelong PE - The epidemiology of subjective PE

Ege Can Serefoglu (Turkey)

02:45 p.m. - 03:00 p.m.

A deeper insight in lifelong PE - The formulation of a new mathematical model for research of the phenotype and genotype of lifelong PE

Paddy Janssen (The Netherlands)

03:00 p.m. - 03:15 p.m.

A deeper insight in lifelong PE - Translational research in PE: from animal to human data

Eelke Snoeren (Norway)

03:15 p.m. - 03:30 p.m.

Debate on topical therapy: Research of local anesthetics for men with Subjective PE should not be investigated in men with Lifelong PE

Marcel Waldinger (The Netherlands)

03:30 p.m. - 03:45 p.m.

Debate on topical therapy: Local anesthetics and coated condoms are a valuable asset in the treatment of lifelong PE

Michael Butcher (USA)

03:45 p.m. - 04:00 p.m.

Male anorgasmia: causes and treatment options

Stacy Elliott (Canada)

02:00 p.m. - 04:00 p.m.

Advancing care for women with female sexual dysfunction

Location: Room 5 B/C in Pavilion 5
Moderators: Leen Aerts (Switzerland), Andrea Burri (United Kingdom) & Anita Clayton (USA)

02:00 p.m. - 02:15 p.m.

From a treatment perspective, should we separate the different types of female sexual dysfunction?

Annamaria Giraldi (Denmark)

02:15 p.m. - 02:30 p.m.

Easy to implement evidence-based strategies for the assessment and treatment of female hypoactive sexual desire disorder

Sue Goldstein (USA)

02:30 p.m. - 02:45 p.m.

Hormonal and non-hormonal pharmacological strategies to manage orgasm dysfunction, post-orgasmic illness and orgasmic anhedonia

Johannes Bitzer (Switzerland)

02:45 p.m. - 03:00 p.m.

IUGA Lecture: Physiotherapy for Sexual pain disorders in women

Bary Berghmans (The Netherlands)

03:00 p.m. - 03:15 p.m.

Same body, different approach: mindfulness in female sexual dysfunction management

Agnes Kocsis (United Kingdom)

03:15 p.m. - 03:30 p.m.

What are the educational requirements for physicians to better manage female sexual dysfunction

Sharon Parish (USA)

03:30 p.m. - 04:00 p.m.

Case discussion

03:00 p.m. - 03:30 p.m.

Sponsored session (non CME)

Location: Auditorium I

03:00 p.m. - 04:00 p.m.

Workshop: Combination-therapies in MSD (ED and EjD) - Which may fit for whom

Location: Auditorium III
Faculty: Hartmut Porst (Germany) & Hossein Sadeghi-Nejad (USA)

03:30 p.m. - 04:00 p.m.

Penile transplantation

Location: Auditorium I
Moderators: Trinity Bivalacqua (USA) & Nikolai Sopko (USA)

03:30 p.m. - 04:00 p.m.

Penile transplantation

Andre Vandermerwe (South Africa)

04:00 p.m. - 04:30 p.m.

Coffee break and poster tours

Location: Pavilion 4 and 5

04:00 p.m. - 04:30 p.m.

Moderated poster tour 6 - Sex and biomedical issues

Location: Pavilion 5
Moderators: Woet Gianotten (The Netherlands), Sidney Glina (Brazil) & Alexander Pastuszak (USA)

Common and uncommon complications after M to F gender affirming genital surgery with vaginoplasty (#231)

M. Garcia (USA)

Efficacy and safety of Volus (hyaluronic acid) for penile girth enhancement: multi-center, randomized, subject blind, active controlled study (#232)

K. Ko (Korea)

Relationship between different types of urinary incontinence and coital incontinence in sexually active women (#233)

D.J. Nale (Serbia and Montenegro)

Serum reactivity to human Hsp60 in women with pelvic inflammatory diseases and sexual dysfunctions (#234)

O. Romashchenko (Ukraine)

Quality of life and sexuality before and 6 months after surgery in breast cancer - a study within the itop trial, a prospective trial evaluating cosmetic and oncologic outcome of immediate techniques of oncoplastic surgery in breast cancer (#235)

L. Maghörndl (Austria)

Sexual dysfunction and marital satisfaction in multiple sclerosis (#236)

M.A. Ramezani (Iran)

04:00 p.m. - 04:30 p.m.

Moderated poster tour 7 - ED: surgical therapy 1

Location: Pavilion 5
Moderators: Daniel Chevallier (France) & Run Wang (USA)

Prosthesis-specific survey: characterizing sexual quality of life in men with a 3-piece penile prosthesis (#237)

E.C. Carlos (USA)

A case series of patients underwent laparoscopic extra-peritoneal radical prostatectomy with simultaneous implant of penile prosthesis: focus on penile length preservation (#238)

Andrea Cocci (Italy)

Glanspexy for floppy glans - outcomes and patient satisfaction (#239)

Marta Skrodzka (Poland)

Surgical outcome and patient’ satisfaction after ZSI 475 penile prosthesis implantation (#240)

V. Vagnoni (Italy)

Comprehensive in-vivo biomechanical study of IPPs yields interesting results (#241)

J.J. Wallen (USA)

Prosthetic sparing surgery: risk factors for infection and keys to success (#242)

J. Slongo (USA)

04:00 p.m. - 04:30 p.m.

Moderated poster tour 8 - Sexual endocrinology 1

Location: Pavilion 5
Moderators: Serge Carrier (Canada) & Casey McCraw (USA)

The association of sex hormone binding globulin with mortality is mediated by age in men with type 2 diabetes (#243)

S. Ramachandran (United Kingdom)

Analysis of microbiome prostatic secretion in depending of levels total testosterone in blood serum (#244)

D.V. Krakhotkin (Russia)

Reference intervals for serum testosterone levels in Korean: results from large health examination data (#245)

M. Kim (Korea)

Serum testosterone profiles in men on testosterone therapy after bilateral orchiectomy (#246)

J. Torremade (USA)

Correlation between testosterone to estradiol ratio and score on the aging males’ symptom scale in late-onset hypogonadism (#247)

T. Suetomi (Japan)

Sexual dysfunction in men with pre-diabetes – results from a cross-sectional study (#248)

Eugenio Ventimiglia (Italy)

04:00 p.m. - 04:30 p.m.

Moderated poster tour 9 - Female sexual function

Location: Pavilion 5
Moderators: Alexandre Kamnerdsiri (Belgium), Becky Lynn (USA) & Gideon Sartorius (Switzerland)

Midurethral sling placement disrupts periurethral neurovascular and glandular structures near anterior vaginal wall: Potential role in female sexual dysfunction (#249)

Johanna Hannan (USA)

Safety and efficacy of high intensity focused ultrasound treatment for vagina-3 months results- (#250)

Y. Sekiguchi (Japan)

FDA 510 K medical clearance for vaginal lubricants: issues and answers (#251)

Michael Krychman (USA)

Facing the transition changes in the puerperium. Couples experience (#252)

E. Gimeno (Spain)

Clitoral reconstruction/transposition after female genital mutilation/cutting: differences in access, refunding, technique, care and outcomes (#253)

J. Abdulcadir (Switzerland)

Vaginal stenosis prevention program: The evidence of practice (#254)

S. Russo (Portugal)

04:30 p.m. - 05:30 p.m.

Innovation platform (non CME)

Location: Auditorium I
Moderators: Maarten Albersen (Belgium) & Faysal Yafi (USA)

04:30 p.m. - 05:30 p.m.

Sex for procreation, effects on recreation

Location: Auditorium II
Moderators: Johannes Bitzer (Switzerland), Sidney Glina (Brazil) & Yiming Yuan (China)

04:30 p.m. - 04:45 p.m.

Evolutionary role of recreation during procreation

Emmanuele Jannini (Italy)

04:45 p.m. - 05:00 p.m.

Family planning and the effects on sexuality

Gideon Sartorius (Switzerland)

05:00 p.m. - 05:15 p.m.

Is there a role of sexual education in the infertile couple?

Eline Dancet (The Netherlands)

05:15 p.m. - 05:30 p.m.

The effect of infertility and infertility treatments on sex life and the couple

Francesca Tripodi (Italy)

04:30 p.m. - 05:30 p.m.

Measuring the sexual response in the lab

Location: Room 5 B/C in Pavilion 5
Moderators: Nelson Bennett (USA) & Gerald Brock (Canada)

04:30 p.m. - 04:45 p.m.

Implicit measures

Charmaine Borg (The Netherlands)

04:45 p.m. - 05:00 p.m.

Measuring sexual response in animal models

James Pfaus (Canada)

05:00 p.m. - 05:15 p.m.

Psychophysiological measures

Pedro Nobre (Portugal)

05:15 p.m. - 05:30 p.m.

Daily diary and experienced sampling methods

Kevan Wylie (United Kingdom)

04:30 p.m. - 05:30 p.m.

Workshop: Education in sexual medicine

Location: Auditorium III
Faculty: Yacov Reisman (The Netherlands) & Alan Shindel (USA)

05:30 p.m. - 06:30 p.m.

Keynote lecture

Location: Auditorium I
Moderators: Mikkel Fode (Denmark) & Wayne Hellstrom (USA)

How conventional thinking slows the future of sexual medicine

Tim Urban (USA)


06:30 p.m. - 07:30 p.m.

Opening ceremony

Location: Auditorium I

07:30 p.m. - 08:30 p.m.

Networking reception and official opening technical exhibition

Location: Pavilion 4